Blue Jet Healthcare Limited (BLUEJET.BO)
INR 584.1
(1.64%)
INR 584.1
(1.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 16.12 Million INR | -53.11% |
| 2022 | 34.4 Million INR | -80.14% |
| 2021 | 173.17 Million INR | -66.45% |
| 2020 | 516.15 Million INR | -33.46% |
| 2019 | 775.65 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 10.78 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 20.95 Million INR | -15.83% |
| 2023 Q4 | 16.12 Million INR | 0.0% |
| 2023 FY | 16.12 Million INR | -53.11% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 24.89 Million INR | -27.65% |
| 2022 Q4 | 34.4 Million INR | 0.0% |
| 2022 FY | 34.4 Million INR | -80.14% |
| 2022 Q2 | - INR | -100.0% |
| 2022 Q1 | 197.36 Million INR | 0.0% |
| 2021 FY | 173.17 Million INR | -66.45% |
| 2020 FY | 516.15 Million INR | -33.46% |
| 2019 FY | 775.65 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 98.811% |
| Biocon Limited | 162.76 Billion INR | 99.99% |
| Concord Biotech Limited | 97.37 Million INR | 83.435% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 99.93% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 98.781% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | 97.25% |
| Panacea Biotec Limited | 209.9 Million INR | 92.315% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | 26.788% |
| Servoteach Industries Limited | 5059.00 INR | -318737.695% |
| SMS Lifesciences India Limited | 1 Billion INR | 98.399% |
| Supriya Lifescience Limited | 54.88 Million INR | 70.609% |
| Syngene International Limited | 5.55 Billion INR | 99.709% |
| TAKE Solutions Limited | 370.85 Million INR | 95.651% |
| Titan Biotech Limited | 83.02 Million INR | 80.573% |
| Transgene Biotek Limited | 140.01 Million INR | 88.479% |
| Vanta Bioscience Limited | 609.53 Million INR | 97.354% |